In vitro pharmacology of the novel enterokinetic R093877.

被引:0
|
作者
Briejer, MR
Meulemans, AL
Bosmans, JP
VanDaele, P
Schuurkes, JAJ
机构
[1] JANSSEN RES FDN, DEPT GASTROINTESTINAL PHARMACOL, B-2340 BEERSE, BELGIUM
[2] JANSSEN RES FDN, DEPT MED CHEM, B-2340 BEERSE, BELGIUM
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A705 / A705
页数:1
相关论文
共 50 条
  • [21] In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633
    Cohan, VL
    Showell, HJ
    Fisher, DA
    Pazoles, CJ
    Watson, JW
    Turner, CR
    Cheng, JB
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 278 (03): : 1356 - 1361
  • [22] In vitro and in vivo pharmacology of NXT629, a novel and selective PPARα antagonist
    Stebbins, Karin J.
    Broadhead, Alex R.
    Cabrera, Geraldine
    Correa, Lucia D.
    Messmer, Davorka
    Bundey, Richard
    Baccei, Christopher
    Bravo, Yalda
    Chen, Austin
    Stock, Nicholas S.
    Prasit, Peppi
    Lorrain, Daniel S.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 809 : 130 - 140
  • [23] THE BIOCHEMICAL PHARMACOLOGY OF (2'-R)- CHLOROPENTOSTATIN, A NOVEL INHIBITOR OF ADENOSINE-DEAMINASE
    JACKSON, RC
    LEOPOLD, WR
    ROSS, DA
    ADVANCES IN ENZYME REGULATION, 1986, 25 : 125 - 139
  • [24] R093877 dose-dependently accelerates delayed gastric emptying in conscious dogs.
    Briejer, MR
    Meulemans, AL
    Wellens, A
    Schuurkes, JAJ
    GASTROENTEROLOGY, 1997, 112 (04) : A705 - A705
  • [25] In vivo and in vitro pharmacology of epibatidine
    Lembeck, F
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (04) : 113 - 113
  • [26] In Vitro Pharmacology of LY2812223, a Novel Group II mGluR Orthosteric Agonist
    Heinz, B.
    Wang, X.
    Vandergriff, A.
    Felder, C.
    McKinzie, D.
    Monn, J.
    Prieto, L.
    Sanger, H.
    Vivier, R.
    CURRENT NEUROPHARMACOLOGY, 2011, 9 : 28 - 29
  • [27] PHARMACOLOGY OF METHDILAZINE (TACARYL (R))
    LISH, PM
    ALBERT, JR
    PETERS, EL
    ALLEN, LE
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1960, 129 (1-2): : 77 - 107
  • [28] A placebo-controlled study to evaluate the effect on colonic transit of R093877 in healthy volunteers.
    Hagger, R
    Benson, M
    Lloyd, R
    Britten, A
    Masoomi, M
    Gaines, G
    Antonelli, K
    Joseph, A
    Kumar, D
    GUT, 1998, 42 : A94 - A94
  • [29] A placebo-controlled study to evaluate the effect on colonic transit of R093877 in healthy volunteers.
    Hagger, R
    Benson, M
    Lloyd, R
    Britten, A
    Masoomi, M
    Gaines, G
    Antonelli, K
    Joseph, A
    Kumar, D
    GASTROENTEROLOGY, 1998, 114 (04) : A759 - A759
  • [30] In vitro antiviral activity and pharmacology of IDX184, a novel and potent inhibitor of HCV replication
    Cretton-Scott, E.
    Perigaud, C.
    Peyrottes, S.
    Licklider, L.
    Camire, M.
    Larsson, M.
    La Colla, M.
    Hildebrand, E.
    Lallos, L.
    Bilello, J.
    McCarville, J.
    Seifer, M.
    Liuzzi, M.
    Pierra, C.
    Badaroux, E.
    Gosselin, G.
    Surleraux, D.
    Standring, D. N.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S220 - S220